Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Clear Secure Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B), while Clear Secure Inc trades at $42.77 (market cap $4.44B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and Clear Secure Inc pays a 1.33% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Clear Secure Inc for 19 Days on average.
| IOVA | YOU | |
|---|---|---|
Market Cap | $6.04B | $4.44B |
Volume | 14,805,993 | 1,477,828 |
Sector | Health | Technology |
52-Week High | $14.82 | $62.36 |
52-Week Low | $1.81 | $29.61 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $5.97B | $3.59B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Clear Secure (YOU) trades at $43.43, up 2.0% today, with a bullish technical signal despite overbought RSI readings. The company reported strong Q2 2026 results, beating EPS estimates with $0.49 versus $0.40 expected, and revenue growth accelerated to 27% year-over-year. Analyst consensus is mixed with a $61.40 price target, and the stock shows robust profitability with a 90.29% ROE and expanding margins.
The outlook is positive given membership growth and new enterprise initiatives, but risks include high valuation multiples and insider selling. The stock offers growth potential driven by identity platform expansion, though investors should weigh competitive pressures and execution risks against strong fundamental trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
